Fig. 2

Forest plots of the effects of SGLT2i on cardiac structure indexed by body surface area. a LVMI; b LVEDVI; c LVESVI; d LAVI. SGLT2i sodium–glucose cotransporter 2 inhibitors, T2DM type 2 diabetes mellitus, HF heart failure, LVMI left ventricular mass indexed by body surface area, LVEDVI left ventricular end diastolic volume indexed by body surface area, LVESVI left ventricular end systolic volume indexed by body surface area, LAVI left atrial volume indexed by body surface area